On November 24, 2021, in Cargo Systems Messaging Service (CSMS) #50183808, U.S. Customs and Border Protection (CBP) issued guidance on the extensions of 81 Section 301 medical product exclusions related to the COVID-19 pandemic.
The extensions were announced by the Office of the U.S. Trade Representative (USTR) on November 10, 2021. USTR also granted a transition period for the remaining 18 COVID-19 related exclusions, which expired on November 30, 2021. The 81 extended exclusions will expire on May 31, 2022.
CBP directs additional questions on Section 301 entry filing requirements to TradeRemedy@cbp.dhs.gov.
CSMS #50183808 can be found here:
USTR’s notice can be found here: